Facial suture synostosis of newborn Fgfr1P250R/+ and Fgfr2S252W/+ mouse models of Pfeiffer and Apert syndromes

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 91, Issue 7, 2011, Pages 603-609

  Purushothaman, Roopa ^a   Cox, Timothy C ^a,b,c,d   Muga, A Murat ^b,d   Cunningham, Michael L ^a,b,d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c MONASH UNIVERSITY   (Australia)

^d SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

Apert syndrome; Midface; Midfacial; Mouse; Pfeiffer syndrome; Sutures; Synostosis

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 2;

ACROCEPHALOSYNDACTYLY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CRANIOFACIAL SYNOSTOSIS; FEMALE; FRONTAL BONE; HISTOLOGY; MALE; MAXILLA; MICRO-COMPUTED TOMOGRAPHY; MIDFACE HYPOPLASIA; MOUSE; NASAL BONE; NONHUMAN; OSSIFICATION; PALATE; PATHOGENESIS; PRIORITY JOURNAL; SKULL BASE; SYNOSTOSIS;

ACROCEPHALOSYNDACTYLIA; ANIMALS; CRANIOSYNOSTOSES; DISEASE MODELS, ANIMAL; FACE; FEMALE; MALE; MAXILLA; MICE; OSTEOGENESIS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; SKULL BASE;

EID: 79960064424     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20811     Document Type: Article

References (36)

1. Bachler M, Neubüser A. 2001. Expression of members of the Fgf family and their receptors during midfacial development. Mech Dev 100: 313-316.
2. Blentic A, Tandon P, Payton S, et al. 2008. The emergence of ectomesenchyme. Dev Dyn 237: 592-601.
3. Bochukova EG, Roscioli T, Hedges DJ, et al. 2009. Rare mutations of FGFR2 causing apert syndrome: identification of the first partial gene deletion, and an Alu element insertion from a new subfamily. Hum Mutat 30: 204-211.
4. Britto JA, Evans RD, Hayward RD, Jones BM. 2001. From genotype to phenotype: the differential expression of FGF, FGFR, and TGF beta genes characterizes human cranioskeletal development and reflects clinical presentation in FGFR syndromes. Plast Reconstr Surg 108: 2026-2039; discussion 2040-2046.
5. Britto JA, Evans RD, Hayward RD, Jones BM. 2002. Toward pathogenesis of Apert cleft palate: FGF, FGFR, and TGF beta genes are differentially expressed in sequential stages of human palatal shelf fusion. Cleft Palate Craniofac J 39: 332-340.
6. Chen L, Li D, Li C, et al. 2003. A Ser252Trp [corrected] substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis. Bone 33: 169-178.
7. Creuzet S, Couly G, Le Douarin NM. 2005. Patterning the neural crest derivatives during development of the vertebrate head: insights from avian studies. J Anat 207: 447-459.
8. Eswarakumar VP, Monsonego-Ornan E, Pines M, et al. 2002. The IIIc alternative of Fgfr2 is a positive regulator of bone formation. Development 129: 3783-3793.
9. Eswarakumar VP, Lax I, Schlessinger J. 2005. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 16: 139-149.
10. Hajihosseini MK, Lalioti MD, Arthaud S, et al. 2004. Skeletal development is regulated by fibroblast growth factor receptor 1 signalling dynamics. Development 131: 325-335.
11. Hajihosseini MK, Duarte R, Pegrum J, et al. 2009. Evidence that Fgf10 contributes to the skeletal and visceral defects of an Apert syndrome mouse model. Dev Dyn 238: 376-385.
12. Itoh N, Ornitz DM. 2008. Functional evolutionary history of the mouse Fgf gene family. Dev Dyn 237: 18-27.
13. Johnson LE. 1976. The functional matrix hypothesis: reflections in a jaundiced eye. In: McNamara JA, editor. Factors affecting the growth of the midface. Ann Arbor: University of Michigan Press. pp 131-168.
14. Jiang X, Iseki S, Maxson RE, et al. 2002. Tissue origins and interactions in the mammalian skull vault. Dev Biol 241: 106-116.
15. Kimonis V, Gold JA, Hoffman TL, et al. 2007. Genetics of craniosynostosis. Semin Pediatr Neurol 14: 150-161.
16. Kreiborg S, Marsh JL, Cohen MM Jr, et al. 1993. Comparative three-dimensional analysis of CT-scans of the calvaria and cranial base in Apert and Crouzon syndromes. J Craniomaxillofac Surg 21: 181-188.
17. Kress W, Petersen B, Collmann H, Grimm T. 2000. An unusual FGFR1 mutation (fibroblast growth factor receptor 1 mutation) in a girl with non-syndromic trigonocephaly. Cytogenet Cell Genet 91: 138-140.
18. Le Douarin NM, Brito JM, Creuzet S. 2007. Role of the neural crest in face and brain development. Brain Res Rev 55: 237-247.
19. Martínez-Abadías N, Percival C, Aldridge K, et al. 2010. Beyond the closed suture in apert syndrome mouse models: evidence of primary effects of FGFR2 signaling on facial shape at birth. Dev Dyn 239: 3058-3071.
20. McLeod MJ. 1980. Differential staining of cartilage and bone in whole mouse fetuses by alcian blue and alizarin red S. Teratology 22: 299-301.
21. Miki T, Bottaro DP, Fleming TP, et al. 1992. Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proc Natl Acad Sci U S A 89: 246-250.
22. Moss ML, Bromberg BE, Song IC, Eisenman G. 1968. The passive role of the nasal septal cartilage in mid-facial growth. Plast Reconstr Surg 41: 536-542.
23. Nie X. 2005. Cranial base in craniofacial development: developmental features, influence on facial growth, anomaly, and molecular basis. Acta Odontol Scand 63: 127-135.
24. Oldridge M, Zackai EH, McDonald-McGinn DM, et al. 1999. De novo alu-element insertions in FGFR2 identify a distinct pathological basis for Apert syndrome. Am J Hum Genet 64: 446-461.
25. Ornitz DM, Xu J, Colvin JS, et al. 1996. Receptor specificity of the fibroblast growth factor family. J Biol Chem 271: 15292-15297.
26. Orr-Urtreger A, Bedford MT, Burakova T, et al. 1993. Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2). Dev Biol 158: 475-486.
27. Park WJ, Theda C, Maestri NE, et al. 1995. Analysis of phenotypic features and FGFR2 mutations in Apert syndrome. Am J Hum Genet 57: 321-328.
28. Roscioli T, Flanagan S, Kumar P, et al. 2000. Clinical findings in a patient with FGFR1 P252R mutation and comparison with the literature. Am J Med Genet 93: 22-28.
29. Stewart RE, Dixon G, Cohen A. 1977. The pathogenesis of premature craniosynostosis in acrocephalosyndactyly (Apert's syndrome). A reconsideration. Plast Reconstr Surg 59: 699-707.
30. Tokumaru AM, Barkovich AJ, Ciricillo SF, Edwards MS. 1996. Skull base and calvarial deformities: association with intracranial changes in craniofacial syndromes. AJNR Am J Neuroradiol 17: 619-630.
31. Wang Y, Xiao R, Yang F, et al. 2005. Abnormalities in cartilage and bone development in the Apert syndrome FGFR2(+/S252W) mouse. Development 132: 3537-3548.
32. Wilkie AO, Slaney SF, Oldridge M, et al. 1995. Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat Genet 9: 165-172.
33. Yayon A, Zimmer Y, Shen GH, et al. 1992. A confined variable region confers ligand specificity on fibroblast growth factor receptors: implications for the origin of the immunoglobulin fold. EMBO J 11: 1885-1890.
34. Zhou YX, Xu X, Chen L, et al. 2000. A Pro250Arg substitution in mouse Fgfr1 causes increased expression of Cbfa1 and premature fusion of calvarial sutures. Hum Mol Genet 9: 2001-2008.
35. Rosenberg P, Arlis HR, Haworth RD, Heier L, Hoffman L, LaTrenta G. 1997. The role of the cranial base in facial growth: experimental craniofacial synostosis in the rabbit. Plast Reconstr Surg 99: 1396-1407.
36. Hajihosseini MK, Wilson S, De Moerlooze L, Dickson C. 2001. A splicing switch and gain-of-function mutation in FgfR2-IIIc hemizygotes causes Apert/Pfeiffer-syndrome-like phenotypes. Proc Natl Acad Sci U S A 98: 3855-3860.